GC Biopharma breaks ground on blood product plant in Indonesia

South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.

Indonesian pharmaceutical companies PT Triman and PT Medquest Jaya Global held a groundbreaking ceremony for the blood product factory in Jababeka Industrial Estate, 35 km east of Jakarta, on the previous day.

The plant will be constructed with transferred technologies from GC Biopharma. It aims to process up to 400,000 liters of raw plasma annually on a 40,000-square-meter site, targeting operation by 2027.

GC Biopharma obtained approval from the Indonesian Ministry of Health in June this year for the construction and technology transfer related to the blood product plant.

It signed a three-party agreement with the Indonesian Red Cross Society and the two pharmaceutical companies in Indonesia.

GC Biopharma previously exported a blood product plant to Thailand for the first time among domestic pharmaceutical firms.

Write to Ji-Hyun Lee at bluesky@hankyung.com